OX40 Ligand (OX40L) Pathway Resource Center
Highlighting unmet needs in atopic dermatitis (AD) and understanding disease pathogenesis
Expert Insights - Unmet Needs, Disease Heterogeneity and Future Treatment Goals

This material is non-promotional and sponsored by Sanofi.
This material is for scientific and medical education purposes only, and is intended only for US healthcare professionals.

© 2025 Sanofi. All Rights Reserved.
Sanofi is a registered trademark of Sanofi or an affiliate.
MAT-US-2410187 v2.0 - R Expiration Date: 10/22/2025